Our common stock is traded on The Nasdaq Global Select Market under the symbol “FPRX. ... investor relations website at investor.fiveprime.com/corporate- ...
Aug 11, 2020 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
The Investor Relations website contains information about Fate Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: fprx | Show results with:fprx
People also ask
Did Amgen acquire five prime therapeutics for $1.9 billion in cash?
Who bought five prime therapeutics?
What is the stock symbol for prime therapeutics?
Mar 4, 2021 · PRNewswire/ -- Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX) ... Financial Services & Investing ... Investor Relations Events ...
Rating
(6)
Based on 6 Wall Street analysts offering 12 month price targets for Five Prime Therapeutics in the last 3 months. The average price target is $38.00 with a high ...
Missing: relations | Show results with:relations
The Investor Relations website contains information about eFFECTOR Therapeutics's business for stockholders, potential investors, and financial analysts.
Missing: fprx | Show results with:fprx
Apr 16, 2021 · "Five Prime fits squarely within Amgen 's leading oncology portfolio and includes bemarituzumab, a Phase 3 trial-ready, first-in-class program ...
View today's Five Prime Therapeutics Inc stock price and latest FPRX news and analysis ... investment amount, and may not be suitable for all investors. Prices ...
Missing: relations | Show results with:relations
Mar 4, 2021 · The deal values FPRX stock at a 79% premium to its previous close, SVB Leerink analyst Geoffrey Porges said in a report to clients. That's ...
I'd like now to introduce your host for today's conference, Martin Forrest, vice president, investor relations and corporate communications. You may begin ...